Vesting of Long Term Incentive Plan Awards

Craneware plc

("Craneware" or the "Company")

Vesting of Long Term Incentive Plan Awards

23 September 2022 - The Board of Craneware plc (AIM: CRW.L), the market leader in Value Cycle solutions for the US healthcare market, announces that on 21 September 2022, under the terms of the Craneware plc Long Term Incentive Plan (2016) ("LTIP"), conditional awards of ordinary shares of 1p each in the Company ("Shares") which were granted to three Directors of the Company, vested to the extent that certain performance conditions were satisfied. 

The net amount of Shares received by each of the Directors from the vested LTIP awards was after payment of the associated tax liabilities. No consideration was payable by each of the Directors to receive the Shares from these LTIP awards.

Following this transaction, Keith Neilson holds 3,440,304 Shares which is 9.68% of the issued share capital of the Company, Craig Preston holds 93,872 Shares which is 0.26% of the issued share capital of the Company and Isabel Urquhart holds 8,300 Shares which is 0.02% of the issued share capital of the Company.

PDMR notification: Keith Neilson

1. Details of the Restricted Person / person closely associated with him or her

a) Name Keith Neilson

2. Reason for the notification

a) Position / status CEO

b) Initial notification / Amendment Initial notification

3. Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

a) Name Craneware plc

b) LEI 213800O2CTJ1YFXNXG05

4. Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a) Description of the financial instrument, type of

instrument Ordinary shares of 1p each in the capital of Craneware plc

b) Identification code ISIN GB00B2425G68

c) Nature of the transaction Vesting of conditional share awards under the Craneware plc Long Term Incentive Plan (2016)

d) Price(s) and volume(s) Volume(s) released from vested awards 6,118,

 Price(s) £0

e) Aggregated information:

i. Aggregated volume Aggregate volume released 6,118

ii. Price Price(s) £0

f) Date of the transaction 2022-09-21

g) Place of the transaction Outside a trading venue

PDMR notification: Craig Preston

1. Details of the Restricted Person / person closely associated with him or her

a) Name Craig Preston

2. Reason for the notification

a) Position / status CFO

b) Initial notification / Amendment Initial notification

3. Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

a) Name Craneware plc

b) LEI 213800O2CTJ1YFXNXG05

4. Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a) Description of the financial instrument, type of

instrument Ordinary shares of 1p each in the capital of Craneware plc

b) Identification code ISIN GB00B2425G68

c) Nature of the transaction Vesting of conditional share awards under the Craneware plc

Long Term Incentive Plan (2016)

d) Price(s) and volume(s) Volume(s) released from vested awards 4,543, Price(s) £0

e) Aggregated information:

i. Aggregated volume Aggregate volume released 4,543

ii. Price Price(s) £0

f) Date of the transaction 2022-09-21

g) Place of the transaction Outside a trading venue

PDMR notification: Isabel Urquhart

1. Details of the Restricted Person / person closely associated with him or her

a) Name Isabel Urquhart

2. Reason for the notification

a) Position / status Chief People Officer

b) Initial notification / Amendment Initial notification

3. Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

a) Name Craneware plc

b) LEI 213800O2CTJ1YFXNXG05

4. Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a) Description of the financial instrument, type of

instrument Ordinary shares of 1p each in the capital of Craneware plc

b) Identification code ISIN GB00B2425G68

c) Nature of the transaction Vesting of conditional share award under the Craneware plc

Long Term Incentive Plan (2016)

d) Price(s) and volume(s) Volume(s) released from vested award 1,723, Price(s) £0

e) Aggregated information:

i. Aggregated volume Aggregate volume released 1,723

ii. Price Price(s) £0

f) Date of the transaction 2022-09-21

g) Place of the transaction Outside a trading venue

For further information, please contact:

Craneware plc +44 (0)131 550 3100

Keith Neilson, CEO

Craig Preston, CFO

Alma (Financial PR) +44 (0)20 3405 0205

Caroline Forde, Hilary Buchanan, Joe Pederzolli craneware@almapr.co.uk

Peel Hunt (NOMAD and Joint Broker) +44 (0)20 7418 8900

Dan Webster, Andrew Clark

Investec Bank PLC (Joint Broker) +44 (0)20 7597 5970

Patrick Robb, Henry Reast, Sebastian Lawrence

Berenberg (Joint Broker) +44 (0)20 3207 7800

Mark Whitmore, Richard Andrews, Alix Mecklenburg-Solodkoff

About Craneware

We at The Craneware Group of companies, including our latest additions Sentry Data Systems and Agilum Healthcare Intelligence, passionately believe we can impact healthcare profoundly by delivering the insights healthcare organisations need to also transform the business of healthcare. Our shared vision is to be the operational and financial partner for US healthcare providers.

Our combined suite of applications and industry-leading team of experts help our customers contextualise operational, financial, and clinical data, providing insights that clearly demonstrate what great looks like. These value cycle insights deliver revenue integrity and 340B compliance, as well as margin and operational intelligence- something no other single partner can provide.

Together, approximately 40% of registered U.S. hospitals are now our customers, including more than 12,000 US hospitals, health systems and affiliated retail pharmacies and clinics. Our customers are operating with a financial impact of nearly half a trillion dollars. We have data sets from customers covering more than 150 million unique patients encounters.

Learn more at www.thecranewaregroup.com